California Public Employees Retirement System Intercept Pharmaceuticals, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$15.46 - $24.5 $820,926 - $1.3 Million	-53,100 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$24.48 - $42.47 $146,708 - $254,522	-5,993 Reduced 10.14%	53,100 $1.31 Million
Q3 2020 Nov 05, 2020	BUY	$39.09 - $53.44 $66,453 - $90,848	1,700 Added 2.96%	59,093 $2.45 Million
Q2 2020 Aug 12, 2020	BUY	$46.7 - $92.04 $63,698 - $125,542	1,364 Added 2.43%	57,393 $2.75 Million
Q1 2020 May 12, 2020	SELL	$48.35 - $118.68 $1.35 Million - $3.32 Million	-27,936 Reduced 33.27%	56,029 $3.53 Million
Q4 2019 Jan 27, 2020	BUY	$57.36 - $124.1 $2.18 Million - $4.71 Million	37,936 Added 82.42%	83,965 $10.4 Million
Q3 2019 Oct 31, 2019	BUY	$58.69 - $80.46 $817,845 - $1.12 Million	13,935 Added 43.42%	46,029 $3.05 Million
Q2 2019 Aug 15, 2019	BUY	$77.77 - $120.68 $78,236 - $121,404	1,006 Added 3.24%	32,094 $2.55 Million
Q1 2019 May 03, 2019	BUY	$91.83 - $120.68 $112,308 - $147,591	1,223 Added 4.1%	31,088 $3.48 Million
Q4 2018 Feb 08, 2019	BUY	$85.79 - $126.46 $408,789 - $602,581	4,765 Added 18.98%	29,865 $3.01 Million
Q3 2018 Nov 13, 2018	SELL	$88.49 - $127.55 $168,131 - $242,345	-1,900 Reduced 7.04%	25,100 $3.17 Million
Q2 2018 Aug 15, 2018	SELL	$60.0 - $85.67 $318,000 - $454,051	-5,300 Reduced 16.41%	27,000 $2.27 Million
Q4 2017 Feb 06, 2018	BUY	$58.2 - $72.76 $46,560 - $58,208	800 Added 2.54%	32,300 $1.89 Million
Q3 2017 Nov 15, 2017	BUY	$57.01 - $118.75 $1.8 Million - $3.74 Million	31,500	31,500 $1.83 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account